
Vrajesh K. Pandya, PhD, DABCC
Medical Director: Clinical Chemistry and Toxicology
Assistant Professor (Clinical), University of Utah School of Medicine
Specialties
- Clinical chemistry
- Toxicology
- Cancer biomarkers
Education
- Doctorate—University of Alberta
- Postdoctoral Fellowship—Biochemistry, University of Alberta
- Postdoctoral Fellowship—Clinical Chemistry, University of Utah School of Medicine
Certification/Affiliations
- American Board of Clinical Chemistry (Clinical Chemistry)
Research Interests
- Renal function testing
- Cancer biomarkers
- Interferences in laboratory assays
- Drugs of abuse
- Testing in alternative specimen types
Awards
- AACC Annual Meeting Travel Award (North American Chinese Clinical Chemists Association, 2021)
- Paul E. Strandjord Young Investigator (Academy of Clinical Laboratory Physicians and Scientists, 2021)
- Medical and Scientific Learning Exchange Program (Siemens Healthineers, 2021)
- Oral presentation award at Residents and Fellows Research Grand Rounds (Department of Pathology, University of Utah, 2021)
- MSACL LC-MS/MS 101 Course Scholarship (SCIEX, 2021)
- Best PhD Thesis in Biochemistry (Department of Biochemistry, University of Alberta, 2019)
- Oral Presentation Award (Women’s and Children’s Health Research Institute, 2019)
- CSCC Annual Meeting Travel Award (Graduate Students’ Association, University of Alberta, 2019)
- Canadian Cancer Research Conference Travel Award (Canadian Institutes of Health Research, 2017)
- Canadian Cancer Research Conference Travel Award (Cancer Research Institute of Northern Alberta, 2017)
- Med Star Award for best publication by a graduate student in the Faculty of Medicine and Dentistry (University of Alberta, 2016)
- Best Poster Award (Department of Biochemistry, University of Alberta, 2016)
- Doctoral Recruitment Scholarship (University of Alberta, 2012)
- Junior Research Fellowship (Council for Scientific and Industrial Research, Government of India, 2012)
Recent Publications
- Pandya V, et al. Can umbilical cord and meconium results be directly compared? Analytical approach matters. J Anal Toxicol. 2022 [Published online ahead of print Jun 2022]
- Pandya V, et al. Connected by the cord—comparison of drug positivity rates and concentrations in a large cohort of paired umbilical cord and meconium specimens. Am J Clin Pathol. 2021;156, Supplement_1.
- Pandya V, et al. Excessively low cholesterol and triglyceride levels in an apparently healthy patient. Clin Biochem. 2021;96:78–81.
- Githaka JM, et al. BAD regulates mammary gland morphogenesis by 4E-BP1-mediated control of localized translation in mouse and human models. Nat Commun. 2021;12:2939.
- Klionsky DJ, et al. Guidelines for the use and interpretation of assays for monitoring autophagy−4th edition. Autophagy. 2021;17(1):1–382.
- Salla M, et al. Resveratrol and resveratrol-aspirin hybrid compounds as potent intestinal anti-inflammatory and anti-tumor drugs. Molecules. 2020;25(17):3849.
- Pandya V, et al. BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer. Cell Death and Dis. 2020;11(6):448.
- Salla M, et al. Identification and characterization of novel receptor interacting serine/threonine‐protein kinase 2 (RIPK2) inhibitors using structural similarity analysis. J Pharmacol Exp Ther. 2018;365(2):354–67.